Walleye Capital LLC Pliant Therapeutics, Inc. Transaction History

Walleye Capital LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$18.73 - $36.26 $22,719 - $43,983	1,213 New	1,213 $32,000
Q3 2022 Nov 14, 2022	BUY	$7.67 - $24.23 $1.17 Million - $3.7 Million	152,741 New	152,741 $3.19 Million
Q2 2022 Aug 08, 2022	SELL	$4.11 - $8.75 $979,228 - $2.08 Million	-238,255 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$7.01 - $14.1 $739,393 - $1.49 Million	105,477 Added 79.44%	238,255 $1.67 Million
Q4 2021 Mar 03, 2022	BUY	$12.27 - $18.26 $1.28 Million - $1.9 Million	104,093 Added 362.88%	132,778 $1.79 Million
Q3 2021 Nov 15, 2021	BUY	$16.48 - $28.98 $472,728 - $831,291	28,685 New	28,685 $484,000

168

63.2M

245K

373K

Ticker PLRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,682,000
Market Cap $600M
Description
Pliant Therapeutics, Inc., a clinical stage biopharmaceutical company, discovers, develops, and commercializes novel therapies for the treatment of fibrosis and related diseases in the United States. Its lead product candidate is PLN-74809, an oral small-molecule dual selective inhibitor of avß6 and avß1 integrins, which is in three Phase 2a tri...

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Capital LLC with notifications on news.